Blood glucose monitoring in the intensive care unit: Toward defining bias and imprecision thresholds for (near) continuous sensors

Clinical Chemistry

Volumn 60, Issue 4, 2014, Pages 577-579

  Van Den Berghe, Greet ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

BLOOD GLUCOSE MONITORING; GLUCOSE BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSOR;

BLOOD GLUCOSE; COMPUTER SIMULATION; DECISION SUPPORT SYSTEMS, CLINICAL; HUMANS;

EID: 84897553276     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.220715     Document Type: Review

References (16)

1. van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
2. van Den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61. (Pubitemid 43200296)
3. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van Den Heuvel I, et al. Intensive insulin therapy in paediatric intensive care unit patients: A prospective randomized controlled study. Lancet 2009;373:547-56.
4. Mesotten D, Gielen M, Sterken C, Claessens K, Hermans G, Vlasselaers D, et al. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: A randomized controlled trial. JAMA 2012;308:1641-50.
5. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-97.
6. Van Den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D. Clinical review: intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab 2009;94:3163-70.
7. Poesen K, De Prins M, Van Den Berghe G, Van Eldere J, Vanstapel F. Performance of cassette-based blood gas analyzers to monitor blood glucose and lactate levels in a surgical intensive care setting. Clin Chem Lab Med 2013;51:1417-27.
8. Vlasselaers D, Van Herpe T, Milants I, Eerdekens M, Wouters PJ, De Moor B, Van Den Berghe G. Blood glucose measurements in arterial blood of intensive care unit patients submitted to tight glycemic control: Agreement between bedside tests. J Diabetes Sci Technol 2008;2:932-8.
9. Boyd JC, Bruns DE. Mont Carlo simulation in establishing analytical quality requirements for clinical laboratory tests: meeting clinical needs. Methods Enzymol 2009;467:411-33.
10. Cembrowski GS, Tran DV, Slater-Maclean L, Chin D, Gibney RT, Jacka M. Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial? Clin Chem 2010;56:1193-5.
11. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van Den Berghe G. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010;38:1021-9.
12. Sacks DB, Bruns DE, Horton J, Lindberg S, Mahoney JJ, Manzella S, et al. Point-of-care blood glucose testing in acute and chronic care facilities: Approved guideline. 3rd ed. CLSI document POCT12-A3. Wayne (PA): CLSI; 2013. p 1-48.
13. Boyd JC, Bruns DE. Effects of measurement frequency on analytical quality required for glucose measurements in intensive care units: Assessments by simulation models. Clin Chem 2014;60:644-50.
14. Hovorka R, Chassin LJ, Ellmerer M, Plank J, Wilinska ME. A simulation model of glucose regulation in the critically ill. Physiol Meas 2008;29:959-78.
15. Van Herpe T, Espinoza M, Haverbeke N, De Moor B, Van Den Berghe G. Glycemia prediction in critically ill patients using an adaptive modeling approach. J Diabetes Sci Technol 2007;1:348-56.
16. Van Herpe T, Mesotten D, Wouters PJ, Herbots J, Voets E, Buyens J, et al. LOGIC-insulin algorithm-guided versus nurse-directed blood glucose control during critical illness: the LOGIC-1 single-center, randomized, controlled clinical trial. Diabetes Care 2013;36:188-94.